Bank Of New York Mellon Corp Acumen Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.08 - $4.88 $212,430 - $336,578	-68,971 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$3.91 - $6.73 $194,682 - $335,093	49,791 Added 259.6%	68,971 $270,000
Q4 2021 Feb 11, 2022	BUY	$6.54 - $15.31 $8,076 - $18,907	1,235 Added 6.88%	19,180 $129,000
Q3 2021 Nov 12, 2021	BUY	$14.5 - $20.28 $260,202 - $363,924	17,945 New	17,945 $266,000

41.8M

57.7K

749K

Ticker ABOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,503,100
Market Cap $72.5M
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.